Journal of Hepatology
Volume 53, Issue 2 , Pages 267-272 , August 2010

Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: Results of a randomized controlled trial

  • Oliviero Riggio

      Affiliations

    • II Gastroenterologia, Dipartimento di Medicina Clinica, “La Sapienza” Università di Roma, Italy
    • Corresponding Author InformationCorresponding author. Address: II Gastroenterologia, Dipartimento di Medicina Clinica, “La Sapienza” Università di Roma, Viale dell’Università 37, 00185 Roma, Italy. Tel./fax: +39 0649972001; fax: +39 064453319.
    • ,
  • Lorenzo Ridola

      Affiliations

    • II Gastroenterologia, Dipartimento di Medicina Clinica, “La Sapienza” Università di Roma, Italy
    • ,
  • Stefania Angeloni

      Affiliations

    • II Gastroenterologia, Dipartimento di Medicina Clinica, “La Sapienza” Università di Roma, Italy
    • ,
  • Federica Cerini

      Affiliations

    • II Gastroenterologia, Dipartimento di Medicina Clinica, “La Sapienza” Università di Roma, Italy
    • ,
  • Chiara Pasquale

      Affiliations

    • II Gastroenterologia, Dipartimento di Medicina Clinica, “La Sapienza” Università di Roma, Italy
    • ,
  • Adolfo Francesco Attili

      Affiliations

    • II Gastroenterologia, Dipartimento di Medicina Clinica, “La Sapienza” Università di Roma, Italy
    • ,
  • Fabrizio Fanelli

      Affiliations

    • Dipartimento di Scienze Radiologiche, “La Sapienza” Università di Roma, Italy
    • ,
  • Manuela Merli

      Affiliations

    • II Gastroenterologia, Dipartimento di Medicina Clinica, “La Sapienza” Università di Roma, Italy
    • ,
  • Filippo Maria Salvatori

      Affiliations

    • Dipartimento di Scienze Radiologiche, “La Sapienza” Università di Roma, Italy

Received 1 December 2009 ,Revised 25 February 2010 ,Accepted 25 February 2010.

References 

  1. Cabrera J, Maynar M, Granados R, et al. Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage. Gastroenterology. 1996;110:832–839
  2. Sanjal AJ, Freedman AM, Luketic VA, et al. Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy. Gastroenterology. 1996;111:138–146
  3. Rossle M, Deibert P, Haag K, et al. Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. Lancet. 1997;349:1043–1049
  4. Merli M, Salerno F, Riggio O, et al. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. Hepatology. 1998;27:40–45
  5. Lebrec D, Giuily N, Hadengue A, et al. Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patient with cirrhosis and refractory ascites: a randomized trial. J Hepatol. 1996;25:135–144
  6. Rossle M, Ochs A, Gulberg V, et al. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med. 2000;342:1701–1707
  7. Gines P, Uriz J, Calahorra B, et al. Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology. 2002;123:1839–1847
  8. Sanyal AJ, Genning C, Reddy KR, et al. The North American study for the treatment of refractory ascites. Gastroenterology. 2003;124:634–641
  9. Salerno F, Merli M, Riggio O, et al. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites. Hepatology. 2004;40:629–635
  10. Lind CD, Malisch TW, Chong WK, et al. Incidence of shunt occlusion or stenosis following transjugular intrahepatic portosystemic shunt placement. Gastroenterology. 1994;106:1277–1283
  11. LaBerge JM, Somberg KA, Lake JR, et al. Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology. 1995;108:1143–1151
  12. Nazarian GK, Ferral H, Castaneda-Zuniga WR, et al. Development of stenoses in transjugular intrahepatic portosystemic shunts. Radiology. 1994;192:231–234
  13. Latimer J, Bawa SM, Rees CJ, et al. Patency and reintervention rates during routine TIPSS surveillance. Cardiovasc Intervent Radiol. 1998;21:234–239
  14. Sanjal AJ, Freedman A, Shiffman ML, et al. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study. Hepatology. 1994;20:46–55
  15. Jalan R, Elton RA, Redhead DN, et al. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic shunt for variceal haemorrhage. J Hepatol. 1995;23:123–128
  16. Somberg KA, Riegler JL, LaBerge JM, et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: incidence and risk factors. Am J Gastroenterol. 1995;90:549–555
  17. Riggio O, Merli M, Pedretti R, et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Incidence and risk factors. Dig Dis Sci. 1996;41:578–584
  18. Zuckerman DA, Darcy MD, Bocchini TP, et al. Encephalopathy after transjugular intrahepatic portosystemic shunt: analysis and incidence of potential risk factors. Am J Radiol. 1997;169:1727–1731
  19. Nolte W, Wiltfang J, Schindler C, et al. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric and electroencephalographic investigations. Hepatology. 1998;28:1215–1225
  20. Cejna M, Peck-Radosavljevic M, Thurnher SA, et al. Creation of transjugular intrahepatic portosystemic shunts with stent-grafts: initial experiences with a polytetrafluoroethylene-covered nitinol endoprothesis. Radiology. 2001;221:437–446
  21. Otal P, Smayra T, Bureau C, et al. Preliminary results of a new expanded-polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt procedures. Am J Roentgenol. 2002;178:141–147
  22. Maleaux G, Nevens F, Wilmer A, et al. Early and long-term clinical and radiological follow-up results of expanded polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunt procedures. Eur Radiol. 2004;14:1842–1850
  23. Angermayr B, Cejna M, Koeing F, et al. Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stent-grafts versus bare stents. Hepatology. 2003;38:1043–1050
  24. Charon JPM, Alaedin FH, Pimphalwar SA, et al. Results of polytetrafluoroethylene-covered stent grafts for transjugular portosystemic shunt creation. J Vasc Interv Radiol. 2004;15:1219–1230
  25. Vignali C, Bargellini I, Grosso M, et al. TIPS with expanded polytetrafluoroethylene-covered stent: results of an Italian multicenter study. Am J Roentgenol. 2005;185:472–480
  26. Barrio J, Ripoll C, Banares R, et al. Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents. Eur J Radiol. 2005;55:120–124
  27. Ockenga J, Kroencke TJ, Schuetz T, et al. Covered transjugular intrahepatic portosystemic stents maintain lower portal pressure and require fewer reinterventions than uncovered stents. Scand J Gastroenterol. 2004;10:994–999
  28. Bureau C, Garcia-Pagan JC, Otal P, et al. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology. 2004;126:469–475
  29. Angeloni S, Merli M, Salvatori F, et al. Polytetrafluoroethylene-covered stent-graft for TIPS procedure: 1-year patency and clinical results. Am J Gastroenterol. 2004;99:280–285
  30. Tripathi D, Ferguson J, Barkell H, Macbeth K, Ireland H, Redhead DN, et al. Improved clinical outcome with transjugular intrahepatic portosystemic stent-shunt utilizing polytetrafluoroethylene-covered stents. Eur J Gastroenterol Hepatol. 2006;18:225–232
  31. Riggio O, Angeloni S, Salvatori FM, De Santis A, Cerini F, Farcomeni A, et al. Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts. Am J Gastroenterol. 2008;103:2738–2746
  32. Riggio O, Masini A, Efrati C, et al. Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study. J Hepatol. 2005;42:674–679
  33. Sarfeh IJ, Rypins EB. Partial versus total portacaval shunt in alcoholic cirrhosis: results of a prospective, randomized clinical trial. Ann Surg. 1994;219:353–361
  34. Sampietro G, Rossi P, Di Marco P. Use of a laryngeal mask in transjugular intrahepatic portosystemic shunt procedures. J Vasc Interv Radiol. 1998;9:169
  35. Rossi P, Salvatori F, Fanelli F, et al. Polytetrafluoroethylene-covered nitinol stent-graft for transjugular intrahepatic portosystemic shunt creation: 3-year experience. Radiology. 2004;231:820–830
  36. Pugh RNH, Murray Lyon IM, Dawson JC. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646–664
  37. Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31:864–871
  38. The Italian Liver Cirrhosis Project. Reliability of endoscopy in the assessment of varices features. J Hepatol. 1987;4:93–98
  39. Conn HO, Leevy CM, Vlahcevic ZR, et al. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology. 1977;72:573–583
  40. Nicolao F, Efrati C, Masini A, Merli M, Attili AF, Riggio O. Role of determination of partial pressure of ammonia in cirrhotic patients with and without hepatic encephalopathy. J Hepatol. 2003;38:441–446
  41. Amodio P, Wenin H, Del Piccolo F, et al. Variability of trail making test, symbol digit test and line trait test in normal people. A normative study taking into account age-dependent decline and sociobiological variables. Aging Clin Exp Res. 2002;14:117–131
  42. De Franchis R. Portal hypertension II. In: Proceedings of the second Baveno international consensus workshop on definitions, methodology, and therapeutic strategies. Oxford: Blackwell Science; 1996.
  43. Kaplan GL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–481
  44. Riggio O, Merli M, Pedretti G, et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: incidence and risk factors. Dig Dis Sci. 1996;41:578–584
  45. Zucherman DA, Darsy MD, Bocchini TP, et al. Encephalopathy after transjugular intrahepatic portosystemic shunting: analysis of incidence and potential risk factors. Am J Roentgenol. 1997;169:1727–1731
  46. Casado M, Bosch J, Garcia-Pagan JC, et al. Clinical events after transjugular intrahepatic portosystemic shunt: correlation with haemodynamic findings. Gastroenterology. 1998;114:1296–1303
  47. Salerno F, Cammà C, Enea M, Rössle M, Wong F. Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data. Gastroenterology. 2007;133:825–834
  48. Thalheimer U, Leandro G, Samanakis DN, Triantos CK, Senzolo M, Fung K, et al. TIPS for refractory ascites: a single center experience. J Gastroenterol. 2009;44:1089–1095

PII: S0168-8278(10)00329-6

doi: 10.1016/j.jhep.2010.02.033

Journal of Hepatology
Volume 53, Issue 2 , Pages 267-272 , August 2010

Article Tools

* Image Usage & Resolution